BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25362358)

  • 1. Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells.
    Borcherds W; Theillet FX; Katzer A; Finzel A; Mishall KM; Powell AT; Wu H; Manieri W; Dieterich C; Selenko P; Loewer A; Daughdrill GW
    Nat Chem Biol; 2014 Dec; 10(12):1000-2. PubMed ID: 25362358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved Helix-Flanking Prolines Modulate Intrinsically Disordered Protein:Target Affinity by Altering the Lifetime of the Bound Complex.
    Crabtree MD; Borcherds W; Poosapati A; Shammas SL; Daughdrill GW; Clarke J
    Biochemistry; 2017 May; 56(18):2379-2384. PubMed ID: 28425697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding Kinetics of the Intrinsically Disordered p53 Family Transactivation Domains and MDM2.
    Åberg E; Karlsson OA; Andersson E; Jemth P
    J Phys Chem B; 2018 Jul; 122(27):6899-6905. PubMed ID: 29878773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction.
    Neochoritis CG; Atmaj J; Twarda-Clapa A; Surmiak E; Skalniak L; Köhler LM; Muszak D; Kurpiewska K; Kalinowska-Tłuścik J; Beck B; Holak TA; Dömling A
    Eur J Med Chem; 2019 Nov; 182():111588. PubMed ID: 31421630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein dynamics: tuning disorder propensity in p53.
    Kriwacki RW
    Nat Chem Biol; 2014 Dec; 10(12):987-8. PubMed ID: 25393491
    [No Abstract]   [Full Text] [Related]  

  • 6. A single synonymous mutation determines the phosphorylation and stability of the nascent protein.
    Karakostis K; Vadivel Gnanasundram S; López I; Thermou A; Wang L; Nylander K; Olivares-Illana V; Fåhraeus R
    J Mol Cell Biol; 2019 Mar; 11(3):187-199. PubMed ID: 30252118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding Ensembles of
    Lang L; Perez A
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct observations of conformational distributions of intrinsically disordered p53 peptides using UV Raman and explicit solvent simulations.
    Xiong K; Zwier MC; Myshakina NS; Burger VM; Asher SA; Chong LT
    J Phys Chem A; 2011 Sep; 115(34):9520-7. PubMed ID: 21528875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
    Ithuralde RE; Turjanski AG
    PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction.
    Shan B; Li DW; Brüschweiler-Li L; Brüschweiler R
    J Biol Chem; 2012 Aug; 287(36):30376-84. PubMed ID: 22807444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2.
    Dastidar SG; Lane DP; Verma CS
    J Am Chem Soc; 2008 Oct; 130(41):13514-5. PubMed ID: 18800837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuzzy protein theory for disordered proteins.
    Fuxreiter M
    Biochem Soc Trans; 2020 Dec; 48(6):2557-2564. PubMed ID: 33170209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
    Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
    J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
    Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
    PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using NMR Chemical Shifts to Determine Residue-Specific Secondary Structure Populations for Intrinsically Disordered Proteins.
    Borcherds WM; Daughdrill GW
    Methods Enzymol; 2018; 611():101-136. PubMed ID: 30471686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of Affinity Rather Than Sequence Underlies a Dynamic Evolution of the Motif-Mediated p53/MDM2 Interaction in Ray-Finned Fishes.
    Mihalič F; Arcila D; Pettersson ME; Farkhondehkish P; Andersson E; Andersson L; Betancur-R R; Jemth P
    Mol Biol Evol; 2024 Feb; 41(2):. PubMed ID: 38301272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdm2 facilitates the association of p53 with the proteasome.
    Kulikov R; Letienne J; Kaur M; Grossman SR; Arts J; Blattner C
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10038-43. PubMed ID: 20479273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX.
    Pazgier M; Liu M; Zou G; Yuan W; Li C; Li C; Li J; Monbo J; Zella D; Tarasov SG; Lu W
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4665-70. PubMed ID: 19255450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anchoring intrinsically disordered proteins to multiple targets: lessons from N-terminus of the p53 protein.
    Huang Y; Liu Z
    Int J Mol Sci; 2011 Feb; 12(2):1410-30. PubMed ID: 21541066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.